RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: The domain-specific, stage-limited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease

Dement Geriatr Cogn Disord 13(3):125-129 · 2002 · PMID 11893834

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

6,454편 검색→1,976편 판독→303편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Apolipoprotein E epsilon4 allele effects on specific cognitive domains across Alzheimer disease stages (("apolipoprotein E4"[tiab] OR "APOE4"[tiab] OR "APOE ε4"[tiab] OR "apoE4"[tiab] OR "epsilon 4 allele"[tiab] OR "ε4 allele"[tiab] OR "APOE e4"[tiab] OR "apolipoprotein E"[tiab]) AND (cognition[tiab] OR cognitive[tiab] OR memory[tiab] OR executive function[tiab] OR language[tiab] OR attention[tiab] OR visuospatial[tiab] OR "cognitive domain*"[tiab]) AND ("Alzheimer disease"[MeSH Terms] OR "Alzheimer disease"[tiab] OR "Alzheimer's disease"[tiab] OR "Alzheimer*"[tiab] OR "mild cognitive impairment"[tiab] OR "disease stage*"[tiab] OR preclinical[tiab]))

출판 연도

2023: 46편4620232024: 67편672025: 92편922026: 98편982026

선별된 303편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01older · risk127편

  1. 0.89

    Effect of genetic and vascular risk factors on rates of cognitive decline in early-onset and late-onset Alzheimer's disease

    Li Y, Sanjay AB, Manchella M et al. · Journal of Alzheimer's disease : JAD · 2025

  2. 0.89

    Racial differences in the effect of APOE-epsilon4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study

    Xu C, Acevedo P, Lu Y et al. · International journal of geriatric psychiatry · 2023

  3. 0.88

    Trajectories and timing of accelerated decline in specific memory domains preceding Alzheimer's disease

    Long X, Rong M, Long S et al. · Frontiers in aging neuroscience · 2026

  4. 0.86

    Behavioral Alterations of Spatial Cognition and Role of the Apolipoprotein E-epsilon4 in Patients with MCI Due to Alzheimer's Disease: Results from the BDSC-MCI Project

    Cammisuli DM, Bellocchio V, Milesi A et al. · Journal of clinical medicine · 2024

  5. 0.86

    APOE epsilon4 positivity predicts centrality of episodic memory nodes in patients with mild cognitive impairment: A cohort-based, graph theory-informed study of cognitive networks

    De Marco M, Wright LM, Valera Bermejo JM et al. · Neuropsychologia · 2024

  6. 0.86

    Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study

    Zou H, Luo S, Liu H et al. · The journal of prevention of Alzheimer's disease · 2023

  7. 0.86

    Association of APOE epsilon4 Status With Long-term Declines in Odor Sensitivity, Odor Identification, and Cognition in Older US Adults

    GoodSmith MS, Wroblewski KE, Schumm LP et al. · Neurology · 2023

  8. 0.85

    Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults

    Walters S, Contreras AG, Eissman JM et al. · JAMA neurology · 2023

  9. 0.84

    APOEepsilon4 Carriers Exhibit Objective Cognitive Deficits: A Cross-Sectional Study in a Single Center Trial

    Zeng Y, Du W, Zhang M et al. · Brain sciences · 2024

  10. 0.84

    Role of APOE varepsilon4 and varepsilon2 With Longitudinal Cognitive Decline Among Those With Exceptional Longevity: The LifeAfter90 Study

    Colbeth HL, Posis AIB, Rizvi BM et al. · Neurology · 2026

  11. 0.83

    Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognition

    Bolton CJ, Steinbach M, Khan OA et al. · medRxiv : the preprint server for health sciences · 2023

  12. 0.82

    Low testosterone levels relate to poorer cognitive function in women in an APOE-epsilon4-dependant manner

    Dratva MA, Banks SJ, Panizzon MS et al. · Biology of sex differences · 2024

  13. 0.81

    Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease

    Ma H, Shi Z, Kim M et al. · NeuroImage · 2024

  14. 0.80

    Effectiveness and safety of high-definition transcranial direct current stimulation in patients with mild cognitive impairment: A randomized, triple-blind, sham-controlled trial

    Chu CS, Chang HA, Lin YT et al. · Journal of Alzheimer's disease : JAD · 2025

  15. 0.79

    Effect of Virgin Coconut Oil Supplementation on Cognition of Individuals with Mild-to-Moderate Alzheimer's Disease in Sri Lanka (VCO-AD Study): A Randomized Placebo-Controlled Trial

    Fernando MG, Silva R, Fernando WMADB et al. · Journal of Alzheimer's disease : JAD · 2023

  16. 0.78

    Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognition

    Bolton CJ, Steinbach M, Khan OA et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  17. 0.77

    Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals

    Pettigrew C, Nazarovs J, Soldan A et al. · Alzheimer's research & therapy · 2023

  18. 0.77

    Episodic memory retrieval with increasing task demand: associations with age, APOE4 genotype and Alzheimer's disease pathology

    Askevold F, Schumann-Werner B, Behrenbruch N et al. · Brain communications · 2026

  19. 0.77

    Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function

    Xu Y, Sun Z, Jonaitis E et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  20. 0.77

    Naturalistic assessment of reaction time variability in older adults at risk for Alzheimer's disease

    Welhaf MS, Wilks H, Aschenbrenner AJ et al. · Journal of the International Neuropsychological Society : JINS · 2024

  21. 0.76

    Clinical and neuropsychological profile of Alzheimer's disease in Tunisia and the impact of APOE gene

    Gharbi A, Sghaier I, El Habibi M et al. · Frontiers in genetics · 2026

  22. 0.75

    The influence of APOE status on rate of cognitive decline

    Morrison C, Oliver MD, Berry V et al. · GeroScience · 2024

  23. 0.75

    Interaction between KLOTHO-VS Heterozygosity and APOE epsilon4 Allele Predicts Rate of Cognitive Decline in Late-Onset Alzheimer's Disease

    Chen XR, Shao Y, Sadowski MJ et al. · Genes · 2023

  24. 0.74

    AST/ALT, APOE epsilon4, and Alzheimer's disease progression: A longitudinal cohort study

    Ahn YH, Yang CM, Kim DJ et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  25. 0.74

    Apolipoprotein E moderates the association between Non-APOE Polygenic Risk Score for Alzheimer's Disease and Aging on Preclinical Cognitive Function

    Xu Y, Sun Z, Jonaitis E et al. · medRxiv : the preprint server for health sciences · 2023

  26. 0.74

    Apolipoprotein E4 allele, antibodies against periodontal microorganisms, and cognition in older adults

    Merchant AT, Zhao L, Bawa EM et al. · Journal of Alzheimer's disease reports · 2025

  27. 0.74

    Visit-to-Visit Blood Pressure Variability and Cognitive Decline in Apolipoprotein varepsilon4 Carriers versus Apolipoprotein varepsilon3 Homozygotes

    Sible IJ, Nation DA · Journal of Alzheimer's disease : JAD · 2023

  28. 0.71

    Longitudinal deterioration of subjective cognitive decline in apolipoprotein epsilon4 carriers and improvement of subjective cognitive decline by multi-domain intervention for prevention of dementia: The cognitive function instrument assessment

    Osaki T, Oki Y, Kumagai R et al. · Journal of Alzheimer's disease : JAD · 2025

  29. 0.70

    Low premorbid IQ may exacerbate the cognitive effects of apolipoprotein epsilon4 (APOE epsilon4): a multi-ethnic cross-sectional study from HABS-HD

    Abdullah LB, Zhou Z, Alliey NA et al. · Frontiers in neurology · 2025

  30. 0.70

    Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer's disease

    Langella S, Barksdale NG, Vasquez D et al. · Nature communications · 2023

  31. 0.70

    Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer's disease: a neuropsychological data-driven approach

    Putcha D, Katsumi Y, Touroutoglou A et al. · Alzheimer's research & therapy · 2025

  32. 0.70

    Insulin resistance (TyG index) and body mass index as metabolic biomarker combined with ApoE genotype to diagnose Alzheimer's disease

    Chen R, Fan S, Di C et al. · Frontiers in aging neuroscience · 2026

  33. 0.70

    Body Circumference and Cognitive Function: Role of Apolipoprotein E epsilon4 in the Elderly

    Kim JH, Choe YM, Choi HJ et al. · International journal of molecular sciences · 2025

  34. 0.69

    Lifestyle, APOE epsilon4, amyloid burden, and race/ethnicity differences in cognition, mood, and anxiety among cognitively unimpaired older adults

    Li S, Yu Y, Cunanan V et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  35. 0.69

    Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years

    Najar J, Thorvaldsson V, Kern S et al. · Neurobiology of disease · 2023

  36. 0.69

    The Dynamics of Cognitive Decline towards Alzheimer's Disease Progression: Results from ADSP-PHC's Harmonized Cognitive Composites

    Kang K, Zhang P, Dumitrescu L et al. · medRxiv : the preprint server for health sciences · 2025

  37. 0.68

    Apolipoprotein E e4 Status Predicts Memory Performance and Daily Functioning in Aging Hispanic/Latino Adults

    Lozano J, Hernandez E, Beacham D et al. · Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026

  38. 0.68

    Curation of Mini Mental State Examination (MMSE) Scores in the VA Million Veteran Program (MVP): Applications for Cognitive Aging Research

    Lopez FV, Gillis M, Lee S et al. · medRxiv : the preprint server for health sciences · 2026

  39. 0.68

    The relation of ApoE and COMT gene-gene interactions to cognitive and motor function in community-dwelling older adults: a pilot study

    Pizzonia KL, Suhr JA, Clark LA et al. · Frontiers in aging neuroscience · 2023

  40. 0.68

    The Effects of APOE Alleles, Cognitive Activities, and Social Activities on Cognitive Decline in African Americans

    Nsor NA, Bourassa KJ, Barnes LL et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2024

  41. 0.67

    Selenium and Episodic Memory: The Moderating Role of Apolipoprotein E epsilon4

    Kim SG, Keum M, Choe YM et al. · Nutrients · 2025

  42. 0.67

    APOE epsilon4 and Accelerated Cognitive Decline Among Cognitively Healthy Middle-Aged and Older Adults

    Chung YCE, Chung RH, Hsu CC et al. · JAMA network open · 2026

  43. 0.67

    Psychometric approaches to defining cognitive phenotypes in the Old Order Amish

    Zaman A, Caywood L, Prough M et al. · International journal of geriatric psychiatry · 2023

  44. 0.67

    Direct access to specific autobiographical memories is lower in healthy middle-aged to older adult Apolipoprotein E epsilon4 carriers compared to non-carriers

    Knoff AAW, Bowles B, Andrews-Hanna JR et al. · Journal of neuropsychology · 2025

  45. 0.67

    Age-Dependent and APOE-Modified Associations Between Vascular Risk Factor Patterns and Cognitive Function: A Latent Class Analysis of 44,879 NACC Participants

    Kong Y, Li X, Guan R et al. · Alzheimer disease and associated disorders · 2026

  46. 0.67

    Validation of longitudinal change in proper name recall with pTau217 as a marker of early cognitive decline in cognitively unimpaired adults at risk for Alzheimer's disease dementia

    Basche K, He D, Langhough R et al. · Journal of Alzheimer's disease : JAD · 2026

  47. 0.67

    Manganese level and cognitive decline in older adults with the APOE e4 allele: a preliminary study

    Kim SG, Choe YM, Suh GH et al. · Psychiatry research · 2023

  48. 0.67

    Ginseng intake and Alzheimer disease-specific cognition in older adults according to apolipoprotein epsilon4 allele status

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2023

  49. 0.66

    The dynamics of cognitive decline toward Alzheimer's disease progression: Results from ADSP-PHC's harmonized cognitive composites

    Kang K, Zhang P, Dumitrescu L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  50. 0.66

    Mid-to-Late Life Healthy Lifestyle Modifies Genetic Risk for Longitudinal Cognitive Aging among Asymptomatic Individuals

    Xu Y, Sun Z, Jonaitis E et al. · medRxiv : the preprint server for health sciences · 2024

  51. 0.66

    Multimodal Exercise and Cognitive Training Program Improves Cognitive Function in Amnestic Mild Cognitive Impairment

    Fairchild JK, Myers J, Louras P et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2024

  52. 0.66

    APOE-epsilon4 moderates the association between diet quality and executive function in middle-aged women at increased risk for Alzheimer's disease

    Wessinger CM, Park KS, DuBois SL et al. · Journal of nutritional science · 2026

  53. 0.66

    Sex moderates apolipoprotein E epsilon4 effects on sleep expression and memory retention

    Sattari N, Dave A, Chen IY et al. · medRxiv : the preprint server for health sciences · 2026

  54. 0.65

    Education as a Modifier of Genetic Influence on Cognitive Ability in Older Adults

    Hsu YC, Lin MC, Su MH et al. · Behavior genetics · 2025

  55. 0.65

    GSK-3beta activation mediates apolipoprotein E4-associated cognitive impairment in type 2 diabetes mellitus: A multicenter, cross-sectional study

    Gao Y, Yu H, Liu Y et al. · Journal of diabetes · 2024

  56. 0.65

    Region-based analysis with functional annotation identifies genes associated with cognitive function in South Asians from India

    Abu-Amara H, Zhao W, Li Z et al. · Research square · 2024

  57. 0.64

    The interplay of APOE genotype, plasma levels, and cognitive functions in middle-aged adults with a parental history of Alzheimer's disease

    Mattar YA, Refaat O, El-Makawi S et al. · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2026

  58. 0.64

    Prosocial helping behaviors attenuate accelerated cognitive decline driven by APOE epsilon4

    Han SH, Faul JD · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  59. 0.64

    Cognitive functioning predicts vulnerability to financial exploitation in APOE e4 carriers

    Weissberger GH, Yassine HN, Axelrod J et al. · International psychogeriatrics · 2025

  60. 0.64

    Relationships between hourly cognitive variability and risk of Alzheimer's disease revealed with mixed-effects location scale models

    Aschenbrenner AJ, Hassenstab J, Morris JC et al. · Neuropsychology · 2024

  61. 0.64

    Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction

    Gordon S, Hoey L, McNulty H et al. · BMC medicine · 2025

  62. 0.63

    Longitudinal associations between lipid panel and cognitive decline modified by APOE 4 carrier status in biracial community-dwelling older adults: Findings from the Chicago health and aging project

    Ng TKS, Beck T, Liu X et al. · Archives of gerontology and geriatrics · 2025

  63. 0.63

    Digital Clock Drawing as an Alzheimer's Disease Susceptibility Biomarker: Associations with Genetic Risk Score and APOE in Older Adults

    Thompson LI, Cummings M, Emrani S et al. · The journal of prevention of Alzheimer's disease · 2024

  64. 0.62

    APOE genotypes modify the obesity paradox in dementia

    Shinohara M, Gheni G, Hitomi J et al. · Journal of neurology, neurosurgery, and psychiatry · 2023

  65. 0.62

    Apolipoprotein E epsilon4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial

    Liu X, Sacks FM, Beck T et al. · The American journal of clinical nutrition · 2025

  66. 0.62

    Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial

    Rajji TK, Bowie CR, Herrmann N et al. · JAMA psychiatry · 2025

  67. 0.62

    Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E varepsilon4 with Neuropsychiatric Symptoms in Alzheimer's Disease

    Jiang J, Hong Y, Li W et al. · Journal of Alzheimer's disease : JAD · 2023

  68. 0.62

    The effects of two Alzheimer's disease related genes APOE and MAPT in healthy young adults: An attentional blink study

    Zeng J, Gao Z, Xiong X et al. · Journal of Alzheimer's disease : JAD · 2025

  69. 0.62

    Population intervention models of racial ethnic disparities in cognitive outcomes from cardiometabolic risk factors - HABS-HD

    Hayes CA, Abdullah L, Gills J et al. · Alzheimer's research & therapy · 2025

  70. 0.61

    The Impact of APOE epsilon4 on Neuropsychological Test Performance in Hispanics: The Panama Aging Research Initiative - Health Disparities Study

    Villarreal AE, Rangel GA, Tratner AE et al. · Dementia and geriatric cognitive disorders · 2026

  71. 0.61

    APOE4 carriers resistant to cognitive decline show unique relationships between cerebrovascular response to exercise and dual-task cognitive-balance performance

    Palmer JA, Billinger SA · Frontiers in neuroscience · 2026

  72. 0.61

    Effects of transcranial direct current stimulation on cognition in MCI with Alzheimer's disease risk factors using Bayesian analysis

    Kang DW, Wang SM, Um YH et al. · Scientific reports · 2024

  73. 0.61

    Social support may buffer the effect of APOE epsilon4 allele on cognition in older adults

    Payen A, Bateman JR, Dhanavanthri Muralidhara S et al. · Journal of Alzheimer's disease : JAD · 2024

  74. 0.60

    Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults

    Rajan KB, Mcaninch EA, Wilson RS et al. · Neurology · 2024

  75. 0.60

    Increased sedentary behavior is associated with neurodegeneration and worse cognition in older adults over a 7-year period despite high levels of physical activity

    Gogniat MA, Khan OA, Li J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  76. 0.60

    Protein intake and episodic memory: the moderating role of the apolipoprotein E epsilon4 status

    Keum M, Lee BC, Choe YM et al. · Alzheimer's research & therapy · 2024

  77. 0.60

    Impact of the Apolipoprotein E epsilon4 Allele on Cognition and Omega-3 Fatty Acid Levels in the Plasma Membrane of Red Blood Cells in Healthy Elderly Japanese Population

    Hashimoto M, Matsuzaki K, Matsuda C et al. · Dementia and geriatric cognitive disorders extra · 2025

  78. 0.60

    Exploring the role of depression in the association between APOE epsilon4 and cognitive function: Evidence from the Brain Health Registry

    Wang Y, Ashford MT, Jin C et al. · Journal of psychiatric research · 2026

  79. 0.59

    Higher glycated hemoglobin amplifies the effect of apolipoprotein E epsilon 4-related cognition and olfaction impairments in type 2 diabetes

    Wang YR, Gao Y, Liu YC et al. · World journal of diabetes · 2025

  80. 0.59

    Association between physical activity and episodic memory and the moderating effects of the apolipoprotein E epsilon4 allele and age

    Lee BC, Choe YM, Suh GH et al. · Frontiers in aging neuroscience · 2023

  81. 0.59

    Inhibitory P300 subprocesses and neural compensation in genetic risk for Alzheimer's disease: The case for temporal-spatial principal component analysis

    Paitel ER, Nielson KA · Psychophysiology · 2024

  82. 0.59

    APOE genotype and cognitive decline: educational context as a moderator of genetic risk

    Walsemann KM, Jackson HM, Boardman JD et al. · The journals of gerontology. Series B, Psychological sciences and social sciences · 2025

  83. 0.58

    Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study

    Delgado F, Yu F, Peterson DS et al. · Dementia and geriatric cognitive disorders · 2026

  84. 0.58

    Aperiodic EEG signatures: unveiling the interplay between APOE epsilon4 and mild cognitive impairment subtypes

    Eyamu J, Ku B, Kim K et al. · Frontiers in aging neuroscience · 2025

  85. 0.58

    Dementia, cognitive impairment in Nigerians aged 90 years or older: A 20-year follow up of survivors of Ibadan study of aging cohort

    Baiyewu O, Elugbadebo O, Gao S et al. · International psychogeriatrics · 2026

  86. 0.58

    Walking to protect against cognitive decline: the role of APOE genotype and sex

    Burma JS, Rosano C, Best JR et al. · Biology of sex differences · 2026

  87. 0.58

    News event memory in amnestic and non-amnestic MCI, heritable risk for dementia, and subjective memory complaints

    Asp I, Cawley-Bennett ATJ, Frascino JC et al. · Neuropsychologia · 2024

  88. 0.57

    BDNF expression mediates verbal learning and memory in women in a cohort enriched with risk for Alzheimer's disease

    Edmunds KJ, Pandos AA, Hoang I et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  89. 0.57

    Associations between sex and lifestyle activities with cognitive reserve in mid-life adults with genetic risk for Alzheimer's disease

    Qi Q, Deng F, Sammon R et al. · Alzheimer's research & therapy · 2024

  90. 0.57

    Genetic modifiers of APOE-epsilon4-associated cognitive decline

    Contreras AG, Walters S, Eissman JM et al. · Nature communications · 2026

  91. 0.57

    Dynamic trajectories of neuropsychiatric symptoms predict Alzheimer's disease risk and clinical phenotypes

    Liu W, Wang Y, Shi Y et al. · General psychiatry · 2026

  92. 0.57

    ApoE Genotype, Age, and Cognitive Decline in Old Chinese Individuals Without Dementia: A Population-Based Study With Five-Year Follow-Up

    Wu H, Gu X, Liu S et al. · International journal of geriatric psychiatry · 2025

  93. 0.57

    Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies

    Xu Y, Gunasekaran TI, Gu Y et al. · The Lancet. Neurology · 2026

  94. 0.56

    Olfaction, Cognition, and Early Signs of Neurodegenerative Disease in a Community-Based Sample of Older Adults

    Jacobsen E, Zhang Y, Ganguli M et al. · Alzheimer disease and associated disorders · 2026

  95. 0.56

    Genetic Risk for Alzheimer's Disease Alters Perceived Executive Dysfunction in Cognitively Healthy Middle-Aged and Older Adults

    Evans SA, Paitel ER, Bhasin R et al. · Journal of Alzheimer's disease reports · 2024

  96. 0.56

    Correlational Validity and Biomarker Associations of the Korean Computerized Cognitive Function Test Relative to the Seoul Neuropsychological Screening Battery in MCI and Alzheimer's Disease

    Kim D, Lee WJ, Jeon DH et al. · Dementia and geriatric cognitive disorders · 2026

  97. 0.55

    Sex differences in APOE- and PICALM-related cognitive profiles in healthy middle-aged adults

    Bednorz A, Trybek P, Hoang MT et al. · Frontiers in aging · 2025

  98. 0.55

    Assessing episodic and semantic autobiographical recall in healthy older apolipoprotein E epsilon 4 (APOE epsilon4) carriers

    Sacripante R, James T, Melega G et al. · Psychology and aging · 2026

  99. 0.55

    Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample

    Liu X, Beck T, Dhana K et al. · The journal of nutrition, health & aging · 2024

  100. 0.55

    The impact of APOE epsilon4 on cognition in Brazilians with type 2 diabetes: exploring ethnicity effects

    Nohmi RL, de Matos MR, Oba-Shinjo SM et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2025

  101. 0.55

    APOE varepsilon4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals

    Haglin S, Koch E, Schafer Hackenhaar F et al. · Scientific reports · 2023

  102. 0.55

    Relationship Between Apolipoprotein E Genotypes, Unhealthy Weight Status, and Cognitive Impairment in Older Adults of Predominantly African Descent

    Clotilde JP, Nicolas L, Larifla L et al. · Diseases (Basel, Switzerland) · 2025

  103. 0.54

    The associations between sedentary behavior and cognition in a population cohort of older adults

    Gogniat MA, Wang Y, Chang CCH et al. · Journal of Alzheimer's disease : JAD · 2026

  104. 0.54

    Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease-related cognitive decline

    Shang Y, Torrandell-Haro G, Vitali F et al. · Alzheimer's & dementia (New York, N. Y.) · 2025

  105. 0.53

    African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181

    Rajabli F, Seixas AA, Akgun B et al. · Journal of Alzheimer's disease : JAD · 2024

  106. 0.53

    Variability in objective sleep is associated with Alzheimer's pathology and cognition

    Fenton L, Isenberg AL, Aslanyan V et al. · Brain communications · 2023

  107. 0.53

    Correlation between the APOE epsilon4 genotype, lifestyle habits, and cognitive deficits in Chinese adults over 60: a cross-sectional analysis in China

    Li W, Wang X, Sun L et al. · Frontiers in public health · 2024

  108. 0.53

    Polygenicity and APOE epsilon4 shape response to intervention in mild cognitive impairment

    Hwang J, Moon SY, Lee H et al. · Alzheimer's research & therapy · 2025

  109. 0.53

    Sex differences in sleep and memory relationships in older adults at risk for Alzheimer's disease

    Sattari N, Dave A, Chen IY et al. · Frontiers in endocrinology · 2026

  110. 0.53

    Prospective associations of interleukin-6 and APOE allele with cognitive decline in biracial community-dwelling older adults: The Chicago Health and Aging Project (CHAP)

    Ng TKS, Beck T, Desai P et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  111. 0.53

    Obesity reduces hippocampal structure and function in older African Americans with the APOE-epsilon4 Alzheimer's disease risk allele

    Osiecka Z, Fausto BA, Gills JL et al. · Frontiers in aging neuroscience · 2023

  112. 0.52

    Dietary Patterns and Cognitive Decline in Older Adults: Findings from the Western Australia Memory Study

    Blagojevic Castro C, Gardener SL, Jahan F et al. · Nutrients · 2026

  113. 0.52

    Novel genetic profile linked to cognitive decline in Hispanics/Latinos

    Hrytsenko Y, Purushotham Y, Li Z et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  114. 0.52

    A novel approach to resilience and its links with education and Alzheimer's disease genetics

    Carrigan M, Bocancea DI, Vogel J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  115. 0.51

    Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in epsilon4 carriers

    Royall DR, Palmer RF · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  116. 0.51

    The association between activities and cognitive health: Stratified analysis by APOE epsilon4 status

    Lee YJ, Gonzales E, Wu Y et al. · Journal of Alzheimer's disease reports · 2024

  117. 0.51

    Longitudinal assessment of cognitive decline and resilience in high-level Alzheimer disease neuropathologic change

    Richardson TE, Kandoi S, Almeida FC et al. · Alzheimer's research & therapy · 2025

  118. 0.51

    APOE:RAAS epistasis as a population specific risk factor for cognitive impairment and cardiovascular health

    Tucker AE, Barber RC, Zhou Z et al. · Journal of Alzheimer's disease : JAD · 2026

  119. 0.50

    Educational attainment is associated with reduced functional decline in Puerto Ricans with elevated pTau181

    Dorfsman DA, Cai D, Hamilton-Nelson KL et al. · Journal of Alzheimer's disease : JAD · 2026

  120. 0.50

    Cerebellar EEG source localization reveals age-related compensatory activity moderated by genetic risk for Alzheimer's disease

    Paitel ER, Nielson KA · Psychophysiology · 2023

  121. 0.50

    APOE4 carriers resistant to cognitive decline show unique relationships between cerebrovascular response to exercise and dual-task cognitive-balance performance

    Palmer JA, Billinger SA · bioRxiv : the preprint server for biology · 2025

  122. 0.50

    Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype

    L'Heureux JE, Corbett A, Ballard C et al. · PNAS nexus · 2025

  123. 0.50

    Distinct patterns of cognitive traits in extreme old age and Alzheimer's disease

    Nishimoto Y, Sasaki T, Abe Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  124. 0.50

    GWAS links APOE to neuropsychiatric symptoms in mild cognitive impairment and dementia

    Vattathil SM, Blostein F, Miller-Fleming TW et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  125. 0.50

    Older adults at greater risk for Alzheimer's disease show stronger associations between sleep apnea severity in REM sleep and verbal memory

    Lui KK, Dave A, Sprecher KE et al. · Alzheimer's research & therapy · 2024

  126. 0.50

    Psychiatric symptoms and alzheimer's disease: Depression-anxiety comorbidity effects and their neurobiological mediating mechanisms

    Yang J, Xue W, Zheng W et al. · Journal of affective disorders · 2026

  127. 0.50

    Nutritional Status and Cognition in Older Adults: Modification by Apolipoprotein E epsilon4

    Choe YM, Kim JH, Choi HJ et al. · Nutrients · 2026

02matter · volume68편

  1. 0.88

    APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer's disease spectrum: A retrospective observational study

    Kang S, Jeon S, Lee D et al. · European journal of nuclear medicine and molecular imaging · 2026

  2. 0.88

    Amyloid-beta modulates APOE epsilon4 effects on cognition but not on targeted structural or functional connectivity measures over 2 years in pre-dementia adults

    Wei H, Zhang T, Liang Z et al. · Frontiers in aging neuroscience · 2026

  3. 0.85

    Alzheimer's disease pathogenesis and the role of APOE epsilon4 in remodeling functional gradients of the default mode network

    Song W, Gong C, Li Y et al. · Journal of Alzheimer's disease : JAD · 2025

  4. 0.82

    APOE epsilon4-related structural vulnerability in mild cognitive impairment: a subsystem-based analysis of the default mode network

    Yang X, Lyu J, Wang J et al. · Research square · 2026

  5. 0.82

    The moderation and mediation roles of white matter insults in relationship of APOE epsilon4 genotype with Alzheimer's disease and related phenotypes: two longitudinal studies

    Liu KZ, Zhou X, Dong YF et al. · Journal of advanced research · 2026

  6. 0.82

    The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity

    Zhu Y, Wu Y, Lv X et al. · CNS neuroscience & therapeutics · 2024

  7. 0.80

    APOE epsilon4 as a predictor of cognitive decline and its interaction with hippocampal volume in Alzheimer's disease

    Khan FF, Kim JH, Kim JI et al. · Frontiers in aging neuroscience · 2026

  8. 0.80

    Association of apolipoprotein E genotype with cognitive performance: findings from the University of California, Davis Alzheimer's Disease Research Center longitudinal diversity cohort

    Min E, Gavett B, Sapkota S et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  9. 0.79

    The Effect of APOE epsilon4 Allele on Dynamic Local Spontaneous Brain Activity and Functional Integration in Alzheimer's Disease

    Tan Y, Yang D, Ke Z et al. · Human brain mapping · 2025

  10. 0.79

    Ventral hippocampal-postcentral gyrus functional connectivity mediates the association of APOE epsilon4 gene dose, depressive symptoms, and cognitive function in mild cognitive impairment with subsyndromal depression

    Du Y, Li S, Wen Y et al. · Frontiers in aging neuroscience · 2026

  11. 0.79

    APOE varepsilon4 and Insulin Resistance Influence Path-Integration-Based Navigation through Distinct Large-Scale Network Mechanisms

    Lopez-Vilaret KM, Fernandez-Alvarez M, Bierbrauer A et al. · Aging and disease · 2024

  12. 0.78

    APOE epsilon4 influences the dynamic functional connectivity variability and cognitive performance in Alzheimer's disease

    Gong C, Song W, Zhu Z et al. · Journal of Alzheimer's disease : JAD · 2025

  13. 0.78

    Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline

    Wybitul M, Langer N, Hock C et al. · GeroScience · 2025

  14. 0.77

    Estradiol and memory circuitry in the postmenopause: Modification by APOE4

    Schroeder RA, Thurston RC, Wu M et al. · Research square · 2026

  15. 0.74

    Atrophy of the cholinergic regions advances from early to late mild cognitive impairment

    Lai YLL, Hsu FT, Yeh SY et al. · Neuroradiology · 2024

  16. 0.74

    Associations between differential connectivity patterns of executive control networks and APOE varepsilon4 in the Alzheimer continuum

    Han R, Zhang X, Chen Y et al. · Brain research · 2025

  17. 0.73

    APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia

    Vipin A, Kumar D, Soo SA et al. · Alzheimer's research & therapy · 2023

  18. 0.73

    The effect of C-reactive protein and interleukin-3 on mild cognitive impairment with APOE varepsilon4

    Yang X, Chi L, Qiao M et al. · Journal of Alzheimer's disease : JAD · 2025

  19. 0.73

    Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's disease

    Zhang J, Sun L, Yang X et al. · Translational psychiatry · 2026

  20. 0.72

    Altered brain morphometry and its association with cognitive decline and APOE gene in normal people at risk for Alzheimer's disease

    Zhao M, Yang J, Cheng H et al. · Journal of Alzheimer's disease : JAD · 2025

  21. 0.71

    Hippocampal connectivity and memory decline in cognitively intact APOE epsilon4 carriers

    Baxter LC, Limback-Stokin M, Patten KJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  22. 0.70

    A study on the correlation between APOE gene polymorphism, white matter hyperintensities, and neuropsychiatric symptom phenotypes in Alzheimer's disease

    Fan W, Wang Z, Wan S et al. · Frontiers in psychiatry · 2026

  23. 0.70

    Heterogeneous progression of AT(N) biomarkers in data-driven subtypes of Alzheimer's disease

    Teng Z, Hu M, Zhang Z et al. · Frontiers in aging neuroscience · 2026

  24. 0.69

    Longitudinal functional connectivity during rest and task is differentially related to Alzheimer's pathology and episodic memory in older adults

    Fischer L, Adams JN, Molloy EN et al. · Scientific reports · 2025

  25. 0.69

    Plasma NfL is associated with the APOE epsilon4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults

    Malek-Ahmadi M, Su Y, Ghisays V et al. · Alzheimer's research & therapy · 2023

  26. 0.69

    Longitudinal effects of sex differences and apolipoprotein E genotype on white matter engagement among elderly

    Zhang H, Zhang J, Hsu CL et al. · Brain communications · 2025

  27. 0.69

    Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer's disease

    Vereb D, Mijalkov M, Chang YW et al. · Alzheimer's research & therapy · 2023

  28. 0.68

    The effect of the apolipoprotein E epsilon4 allele and olfactory function on odor identification networks

    Frank C, Albertazzi A, Murphy C · Brain and behavior · 2024

  29. 0.68

    Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults

    Fischer L, Adams JN, Molloy EN et al. · Alzheimer's research & therapy · 2025

  30. 0.68

    APOEepsilon4 alters ApoE and Fabp7 in frontal cortex white matter in prodromal Alzheimer's disease

    Moreno-Rodriguez M, Perez SE, Malek-Ahmadi M et al. · Journal of neuroinflammation · 2025

  31. 0.67

    Longitudinal effects of cerebrovascular reactivity and cerebral pulsatility in cognitively intact older adults with APOE4: links with cognition

    Potvin-Jutras Z, Tremblay PL, Mohammadi H et al. · GeroScience · 2026

  32. 0.67

    Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE varepsilon4 carriers

    Quiring M, Kapoor A, Alitin JPM et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  33. 0.67

    Impact of age and apolipoprotein E epsilon4 status on regional white matter hyperintensity volume and cognition in healthy aging

    Van Etten EJ, Bharadwaj PK, Grilli MD et al. · Journal of the International Neuropsychological Society : JINS · 2024

  34. 0.66

    Exploring the impact of APOE varepsilon4 on functional connectivity in Alzheimer's disease across cognitive impairment levels

    Dong K, Liang W, Hou T et al. · NeuroImage · 2025

  35. 0.65

    Increased vulnerability to low-density lipoprotein cholesterol in apolipoprotein E4-positive females: Longitudinal effects on neurodegeneration and cognition

    Tayem AJ, Jaber AB, Altantawi AM et al. · Journal of Alzheimer's disease : JAD · 2026

  36. 0.65

    Relationship between amyloid burden, cholinergic integrity, and cognitive function

    Lee LH, Chou CJ, Shih YC et al. · Journal of Alzheimer's disease : JAD · 2026

  37. 0.64

    A DAT1 gene and APOE epsilon4 interaction is associated with apathy and structural brain changes in mild cognitive impairment and Alzheimer's disease

    Malik R, Beaton D, Ahmed J et al. · Journal of Alzheimer's disease : JAD · 2025

  38. 0.64

    Evidence of APOE4-related brain vulnerabilities in verbal memory systems in midlife women

    Wugalter KA, Thurston RC, Wu M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  39. 0.63

    Interactions between physical exercise, associative memory, and genetic risk for Alzheimer's disease

    Igloi K, Marin Bosch B, Kuenzi N et al. · Cerebral cortex (New York, N.Y. : 1991) · 2024

  40. 0.62

    Using diffusion MRI to relate hippocampal subfield microstructure to delayed verbal memory in cognitively intact individuals at genetic risk for developing Alzheimer's disease

    VanGilder JL, Hooyman A, Hakhu S et al. · Experimental gerontology · 2026

  41. 0.62

    The selective vulnerability of the left fimbria in cognitively normal APOE epsilon4 carriers: a localized structural correlate of high genetic risk for Alzheimer's disease

    Suo Y, Wang L, Zhao Y et al. · Behavioural brain research · 2026

  42. 0.62

    Vulnerability to memory decline in aging - a mega-analysis of structural brain change

    Vidal-Pineiro D, Sorensen O, Stromstrad M et al. · bioRxiv : the preprint server for biology · 2025

  43. 0.62

    Sex and APOE4-specific links between cardiometabolic risk factors and white matter alterations in individuals with a family history of Alzheimer's disease

    Tremblay SA, Nathan Spreng R, Wearn A et al. · Neurobiology of aging · 2025

  44. 0.62

    Multimodal Fusion Analysis of [18F]Florbetapir PET and Multiscale Functional Network Connectivity in Alzheimer's Disease

    Bimali B, Khasayeva N, Ballem AR et al. · bioRxiv : the preprint server for biology · 2025

  45. 0.62

    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults

    Li J, Mountz EJ, Mizuno A et al. · Journal of Alzheimer's disease : JAD · 2023

  46. 0.60

    APOE4 allele-specific associations between diet, multimodal biomarkers, and cognition among Puerto Rican adults in Massachusetts

    Guan Y, Cheng CH, Bellomo LI et al. · Frontiers in aging neuroscience · 2023

  47. 0.59

    Sex-Specific Entorhinal Cortex Functional Connectivity in Cognitively Normal Older Adults with Amyloid-beta Pathology

    Gong L, Liu D, Zhang B et al. · Molecular neurobiology · 2025

  48. 0.59

    Correlation of peripheral olfactomedin 1 with Alzheimer's disease and cognitive functions

    Wei C, Zhang G, Fu X et al. · Translational psychiatry · 2025

  49. 0.59

    Alzheimer's disease and cerebrovascular biomarkers in relation to odor identification in a naturalistic clinical cohort

    Oltra J, Istvanfyova Z, Kalpouzos G et al. · Alzheimer's research & therapy · 2026

  50. 0.58

    APOE epsilon4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia

    Singh NA, Martin PR, Graff-Radford J et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023

  51. 0.58

    The glymphatic system as a therapeutic target: TMS-induced modulation in older adults

    Sundman MH, Liu Y, Chen NK et al. · Frontiers in aging neuroscience · 2025

  52. 0.58

    Gray matter gamma-hydroxy-butyric acid and glutamate reflect beta-amyloid burden at old age

    Schreiner SJ, Van Bergen JMG, Gietl AF et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  53. 0.57

    Alzheimer-related individual factors modulate effects of transcranial direct current stimulation strength on white matter integrity in mild cognitive impairment

    Lee JW, Kim S, Kim S et al. · Scientific reports · 2025

  54. 0.57

    White Matter Abnormalities and Cognition in Aging and Alzheimer Disease

    Peter C, Sathe A, Shashikumar N et al. · JAMA neurology · 2025

  55. 0.57

    Dynamic functional network connectivity and its association with lipid metabolism in Alzheimer's disease

    Zang F, Liu X, Fan D et al. · CNS neuroscience & therapeutics · 2024

  56. 0.57

    Mediation of the Association Between APOE epsilon4 Genotype, Cognition, and Dementia by Neuropathology Imaging Markers in the Rotterdam Study

    Claus JJ, Rosbergen MT, Labrecque JA et al. · Neurology · 2025

  57. 0.56

    Impact of APOE epsilon4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease

    Jin T, Yang H, Liu F et al. · Annals of clinical and translational neurology · 2026

  58. 0.55

    APOE epsilon4 allele status modulates the spatial patterns of progressive atrophy in the temporal lobes after mild traumatic brain injury

    Gan S, Sun Y, Liu K et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024

  59. 0.54

    Dementia risk and thalamic nuclei volumetry in healthy midlife adults: the PREVENT Dementia study

    Shah SN, Dounavi ME, Malhotra PA et al. · Brain communications · 2024

  60. 0.54

    A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings

    Baumeister H, Vogel JW, Insel PS et al. · Brain : a journal of neurology · 2024

  61. 0.54

    Multimodal Neuroimaging and Behavioral Characterization of Aged Female APOE4 Knock-In Rats Reveals a Preclinical Alzheimer's Disease Phenotype

    Cavallaro NJ, Maheswari A, Chukwuemeka T et al. · Genes, brain, and behavior · 2026

  62. 0.53

    Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status

    Caillaud M, Maltezos S, Hudon C et al. · Journal of Alzheimer's disease : JAD · 2023

  63. 0.53

    Associations of apolipoprotein E epsilon4 allele, regional cerebral blood flow, and serum liver function markers in patients with cognitive impairment

    Wang H, Shi L, Luo S et al. · Frontiers in neurology · 2024

  64. 0.53

    A local-to-distant shift in dynamic brain connectivity marks early Alzheimer's risk

    Coca-Pulido A, Solis-Urra P, Contreras-Rodriguez O et al. · GeroScience · 2026

  65. 0.52

    Retinal microvascular alterations and glymphatic dysfunction mediate the association between APOE epsilon4 and cognitive decline in Alzheimer's disease

    Kwapong WR, Wen C, Wang Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  66. 0.52

    Genetic risk of Alzheimer's disease is associated with loss of brain network segregation in midlife

    Deng F, Henson RN, Muniz-Terrera G et al. · Communications biology · 2026

  67. 0.51

    Multimodal Retinal Imaging Correlates With Brain Atrophy and Plasma Biomarkers in Alzheimer's Disease

    Luan X, Shen J, Wang Y et al. · Translational vision science & technology · 2026

  68. 0.50

    Amyloid pathology related to aberrant structure-function coupling of brain networks in Alzheimer's disease: insights from [(18)F]-florbetapir PET imaging

    Chen HJ, Zhang M, Wei M et al. · European journal of nuclear medicine and molecular imaging · 2025

03emission tomography · amyloid50편

  1. 0.92

    Time Course and Severity of Cognitive Changes as a Function of Abeta Positivity and APOE Genotype in Alzheimer Disease

    Vanderlip CR, Stark CEL · Neurology · 2025

  2. 0.90

    APOE4 Increases Susceptibility to Amyloid, Accelerating Episodic Memory Decline

    Vanderlip CR, Stark CEL · bioRxiv : the preprint server for biology · 2024

  3. 0.87

    Effects of APOE epsilon4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment

    Wang X, Zhang C, Liu X et al. · Journal of Alzheimer's disease : JAD · 2026

  4. 0.78

    Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE epsilon4-dependent manner

    Rubinski A, Dewenter A, Zheng L et al. · European journal of nuclear medicine and molecular imaging · 2024

  5. 0.74

    Effects of APOE e4 and Neuropathological Diagnoses on Neuropsychiatric Symptoms: Mediation Analyses and Likely Causation in an Integrated NACC Database

    Goldberg TE, Devanand DP, Fang Z et al. · medRxiv : the preprint server for health sciences · 2024

  6. 0.74

    Body Mass Index Decrease Has a Distinct Association with Alzheimer's Disease Pathophysiology in APOE varepsilon4 Carriers and Non-Carriers

    Li A, Du J, Cai Y et al. · Journal of Alzheimer's disease : JAD · 2023

  7. 0.73

    Sex and APOE genotype differences in amyloid deposition and cognitive performance along the Alzheimer's Continuum

    Pan F, Wang Y, Wang Y et al. · Neurobiology of aging · 2023

  8. 0.72

    Connectivity, Pathology, and ApoE4 Interactions Predict Longitudinal Tau Spatial Progression and Memory

    Ziontz J, Harrison TM, Fonseca C et al. · Human brain mapping · 2024

  9. 0.72

    Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline

    Wybitul M, Buchmann A, Langer N et al. · Neurobiology of aging · 2024

  10. 0.72

    Association of liver function markers and apolipoprotein E epsilon4 with pathogenesis and cognitive decline in Alzheimer's disease

    Han SW, Lee SH, Kim JH et al. · Frontiers in aging neuroscience · 2024

  11. 0.72

    APOE and amyloid-tau pathology in cognitively unimpaired older adults

    Albarran Morillo C, Zheng L, Ghanbarian E et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  12. 0.71

    Orthogonal Contributions of Genetic, Clinical, and Social Determinants of Health Risk Burdens on Alzheimer's Disease Pathophysiology

    Okorie M, Jiang X, Tolosa-Tort P et al. · medRxiv : the preprint server for health sciences · 2026

  13. 0.70

    The concurrent burden of Alzheimer's pathology, cerebral amyloid angiopathy, and microinfarcts on cognitive decline

    You M, Tang C, Liu L et al. · The journal of prevention of Alzheimer's disease · 2026

  14. 0.69

    Apolipoprotein E epsilon4 homozygosity exacerbates retinal and cerebral microvascular dysfunction in Alzheimer's disease: A mediation analysis of vascular contributions to cognitive decline

    Liu Y, Zhu H, Wang Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  15. 0.69

    Periventricular diffusivity reflects APOE epsilon4-modulated amyloid accumulation and cognitive impairment in the Alzheimer's disease continuum

    Chen CL, Son SJ, Schweitzer N et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  16. 0.69

    Performance on complex memory tests is associated with beta-amyloid in individuals at risk of developing Alzheimer's disease

    Kjeldsen PL, Damholdt MF, Madsen LS et al. · Journal of neuropsychology · 2024

  17. 0.69

    Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE epsilon4

    Jung JH, Kong N, Lee S · The journal of prevention of Alzheimer's disease · 2025

  18. 0.68

    Effects of APOE epsilon4 and Neuropathological Diagnoses on Neuropsychiatric Symptoms: Mediation Analyses and Likely Causation in an Integrated National Alzheimer's Coordinating Center Database

    Goldberg TE, Devanand DP, Fang Z et al. · Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024

  19. 0.68

    The CSF p-tau/beta-amyloid 42 ratio correlates with brain structure and fibrillary beta-amyloid deposition in cognitively unimpaired individuals at the earliest stages of pre-clinical Alzheimer's disease

    Cacciaglia R, Shekari M, Salvado G et al. · Brain communications · 2025

  20. 0.67

    Associations of [(18)F]PI-2620 Binding with Memory and Phosphorylated Tau 217 in Cognitively Unimpaired Older Adults

    Maass A, Garcia-Garcia B, Behrenbruch N et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026

  21. 0.67

    Sequential (18)F-AV45/(18)F-AV1451 dual-tracer brain PET imaging in Alzheimer's disease: amyloid-tau deposition, diagnostic performance, cognitive associations, and modulation by APOE epsilon4

    Hu G, Feng L, He L et al. · Frontiers in neurology · 2026

  22. 0.66

    Glymphatic system dysfunction mediates amyloid deposition and cognitive impairment in Alzheimer's disease: a PET/MRI multimodality imaging study

    Xue H, Bi S, Chen Z et al. · EJNMMI research · 2025

  23. 0.65

    Association of circulating proteasome activity with Alzheimer's pathology and cognitive functions in APOE epsilon4 carriers

    Koo BG, Seo HE, Yun Y et al. · Alzheimer's research & therapy · 2026

  24. 0.65

    Synergistic effects of APOE epsilon4 and Alzheimer's pathology on the neural correlates of episodic remembering in cognitively unimpaired older adults

    Trelle AN, Sheng J, Wilson EN et al. · bioRxiv : the preprint server for biology · 2025

  25. 0.62

    Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers

    Fischer L, Molloy EN, Pichet Binette A et al. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025

  26. 0.62

    Multisite chronic pain: association with cognitive decline and post-mortem Alzheimer's biomarkers

    Bell TR, Franz CE, Lerman IR et al. · Brain communications · 2025

  27. 0.62

    Age at menopause, APOE-epsilon4, and Alzheimer's disease risk

    Wood Alexander M, Nyman AJ, Casaletto KB et al. · Research square · 2026

  28. 0.61

    Heterogeneous tau deposition patterns in the preclinical stage link to domain-specific cognitive deficits

    Hojjati SH, Chiang GC, Butler TA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  29. 0.61

    Sleep complaints and genetic risk of Alzheimer's disease in older women: associations with memory and tau deposition

    Lui KK, Wang X, Dratva MA et al. · The journal of prevention of Alzheimer's disease · 2026

  30. 0.60

    Apolipoprotein E epsilon4 and type 2 diabetes cooperatively accelerate amyloid beta and tau neurodegeneration

    Chen Y, Li Z, Luo S et al. · European journal of nuclear medicine and molecular imaging · 2026

  31. 0.60

    Plasma GFAP and language-network tau mediate the effect of amyloid burden on semantic fluency: A mediation analysis

    Han W, Li N, Wang P et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2026

  32. 0.58

    Dual decline in gait and cognition as a high-risk clinical phenotype: differential associations with cerebral amyloid-beta deposition and the apolipoprotein E epsilon4 allele and implications for integrated assessment

    Ren C, Zhu J, Huang L et al. · Frontiers in aging neuroscience · 2026

  33. 0.58

    APOE4 and cognition in intracranial atherosclerosis: beyond Alzheimer's pathology

    Cheng A, Zou Y, Liu L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  34. 0.58

    SV2A PET shows hippocampal synaptic loss in cognitively unimpaired APOE epsilon4/epsilon4 homozygotes

    Snellman A, Tuisku J, Koivumaki M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  35. 0.58

    Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly

    Kim YJ, Yun J, Seo SW et al. · European journal of neurology · 2024

  36. 0.57

    Multimodal axes reveal individualized amyloid- beta , tau, and neurodegeneration coupling in aging and Alzheimer's disease

    Poulakis K, Ioannou K, Bezgin G et al. · medRxiv : the preprint server for health sciences · 2026

  37. 0.57

    Sex differences in the impact of genetic and clinical risk factors for Alzheimer's disease in midlife

    Konishi K, Spets DS, Fisher P et al. · Journal of Alzheimer's disease : JAD · 2025

  38. 0.57

    Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion

    Kakino Y, Hattori Y, Ogata S et al. · Journal of the American Heart Association · 2025

  39. 0.56

    Temporal sequence of amyloid and tau PET positivity: APOE -epsilon4 and sex effects, and implications for Alzheimer's disease progression

    Mila-Aloma M, Hausle I, Petersen KK et al. · medRxiv : the preprint server for health sciences · 2025

  40. 0.56

    Defining the contributions of tau pathology in the amygdala to increasing depressive symptoms in aging

    Markova TZ, Fonseca CS, Ciampa CJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  41. 0.55

    APOE4-specific glymphatic effects on clinical progression in the Alzheimer's Disease Neuroimaging Initiative with pathological correlates in the A4 study

    Saadawy M, Majeed M, Saadawy E · Journal of Alzheimer's disease : JAD · 2026

  42. 0.55

    Sleep duration promotes resistance and resilience to tau in older women at risk for Alzheimer's disease

    Stiver J, Wang X, Lui KK et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  43. 0.54

    Association between APOE-epsilon4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample

    Paradela RS, Justo AFO, Paes VR et al. · Acta neuropathologica communications · 2023

  44. 0.53

    The time interval from amyloid to tau PET positivity varies by age, sex and APOE-epsilon4 status

    Mila-Aloma M, Hausle I, Petersen KK et al. · The journal of prevention of Alzheimer's disease · 2026

  45. 0.53

    Circadian rhythms are associated with higher amyloid-beta and tau and poorer cognition in older adults

    Eckhardt JL, Isenberg L, Aslanyan V et al. · Brain communications · 2025

  46. 0.53

    Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer's disease using deep learning-derived saliency maps

    Li Y, Wang X, Ge Q et al. · EJNMMI physics · 2025

  47. 0.53

    Effects of the APOEvarepsilon4 Allele on the Relationship Between Tau and Amyloid-beta in Early- and Late-Onset Alzheimer's Disease

    Kang JM, Shin JH, Kim WR et al. · Journal of Alzheimer's disease : JAD · 2023

  48. 0.52

    Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer's Disease

    Fortel I, Zhan L, Ajilore O et al. · Journal of Alzheimer's disease : JAD · 2023

  49. 0.50

    Both sides of the bell curve: Base rates of high and low scores in cognitively unimpaired and impaired older adults and their relationship to biomarkers of Alzheimer's disease

    Duff K, Presley C, King JB et al. · Journal of the International Neuropsychological Society : JINS · 2025

  50. 0.50

    APOE epsilon4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly

    Snellman A, Ekblad LL, Tuisku J et al. · Alzheimer's research & therapy · 2023

04biomarkers · cerebrospinal fluid31편

  1. 0.85

    Role of nerve growth factor on cognitive impairment in patients with Alzheimer's disease carrying apolipoprotein E epsilon4

    He M, Liu Z, Lian T et al. · CNS neuroscience & therapeutics · 2024

  2. 0.83

    APOEvarepsilon4 Status and Plasma p-tau181 Levels May Influence Memory and Executive Function Decline in Older Adults Without Dementia

    Wang S, Liu S, Ke S et al. · Journal of Alzheimer's disease : JAD · 2023

  3. 0.82

    The roles of apolipoprotein E epsilon4 on neuropathology and neuroinflammation in patients with Alzheimer's disease

    He M, Lian T, Guo P et al. · CNS neuroscience & therapeutics · 2024

  4. 0.80

    Ancestry-specific effects of APOE on Alzheimer Disease Endophenotypes

    Boeriu AI, Gu T, Fullton-Howard B et al. · medRxiv : the preprint server for health sciences · 2026

  5. 0.79

    Association of APOE-epsilon4 and GAP-43-related presynaptic loss with beta-amyloid, tau, neurodegeneration, and cognitive decline

    Lan G, Du J, Chen X et al. · Neurobiology of aging · 2023

  6. 0.78

    Cerebrospinal fluid glial cell line-derived neurotrophic factor levels interact with APOE epsilon4 genotype to influence cognitive decline in older adults without dementia

    Wang S, Zou S · Journal of Alzheimer's disease : JAD · 2026

  7. 0.77

    CSF Abeta(42) and tau biomarkers in cognitively unimpaired Abeta- middle-aged and older APOE epsilon4 carriers

    Lim YY, Yassi N, Bransby L et al. · Neurobiology of aging · 2023

  8. 0.76

    PICALM Variation Moderates the Relationships of APOE varepsilon4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population

    Liu YB, Wang XJ, Tan L et al. · Journal of Alzheimer's disease : JAD · 2023

  9. 0.75

    Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups

    Dubbelman MA, Hendriksen HMA, Harrison JE et al. · Neurology · 2024

  10. 0.74

    Impact of APOE epsilon4 and epsilon2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease

    Langella S, Bonta K, Chen Y et al. · Alzheimer's research & therapy · 2024

  11. 0.74

    CSF alpha-synuclein aggregation is associated with APOE epsilon4 and progressive cognitive decline in Alzheimer's disease

    Qiang Q, Skudder-Hill L, Toyota T et al. · Neurobiology of aging · 2025

  12. 0.74

    Blood Biomarkers of Alzheimer Disease and Rates of Global and Domain-Specific Cognitive Decline

    Laukka EJ, Ekstrom I, Valletta M et al. · JAMA network open · 2026

  13. 0.73

    Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype

    Laczo M, Svacova Z, Lerch O et al. · Journal of neurology · 2025

  14. 0.71

    Interactive effects of blood-brain barrier breakdown and Alzheimer's disease biomarker status on cognitive decline in older adults without dementia

    Edwards L, Gonzalez AI, Thomas KR et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  15. 0.69

    Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer's Disease

    Tsokolas ZE, Asante I, Tsiknia AA et al. · Research square · 2026

  16. 0.65

    APOE epsilon4 accelerates plasma p-tau217 trajectory: a Bayesian joint longitudinal analysis of ADNI

    Chu KY · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026

  17. 0.65

    Growth-Associated Protein 43 Levels in the Cerebrospinal Fluid Correspond to the Cerebral Blood Flow Alterations in Alzheimer's Dementia Continuum: An Original Study

    Songhori N, Goushky MS, Khaleghi MM et al. · Health science reports · 2025

  18. 0.64

    Higher soluble ADAM10 plasma levels are associated with decreased cognitive performance in older adults carrying APOEepsilon4

    Pelegrini LNdC, Manzine PR, Popolin CP et al. · Neurobiology of aging · 2025

  19. 0.62

    A multivariate plasma pathology-cognition axis reveals biologically anchored residual cognitive heterogeneity across the Alzheimer's disease clinical spectrum

    Han W, Lei S, Li N et al. · Journal of Alzheimer's disease reports · 2026

  20. 0.62

    Elevated plasma GFAP levels in MCI link APOE epsilon4 allele with impaired gait speed

    Sakurai R, Suzuki H, Fujiwara Y et al. · GeroScience · 2026

  21. 0.62

    Chronic pain as a risk factor for Alzheimer's disease pathology: a longitudinal ADNI study

    Bell TR, Franz CE, Fennema-Notestine C et al. · Alzheimer's research & therapy · 2026

  22. 0.61

    Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome

    Iulita MF, Bejanin A, Vilaplana E et al. · Brain communications · 2023

  23. 0.60

    Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline in APOE epsilon4 carriers

    Yang J, Wang J, Chai W et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

  24. 0.60

    Sleep and APOE-epsilon4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults

    Yu X, Zhou X, He Z et al. · CNS neuroscience & therapeutics · 2024

  25. 0.58

    Homocysteine, neurodegenerative biomarkers, and APOE epsilon4 in neurodegenerative diseases

    Lin WZ, Yu D, Xiong LY et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  26. 0.57

    Semantic intrusion errors differentiate between amnestic MCI who are plasma p-tau(217)+ from p-tau(217)- after adjusting for initial learning strength

    Curiel Cid RE, Vaillancourt D, Ortega A et al. · Frontiers in neurology · 2025

  27. 0.54

    APOE epsilon4-specific associations between agitation, cerebrospinal fluid biomarkers, and cognitive decline in cognitively impaired patients

    Du X, Wang Y, Zhao J et al. · Journal of Alzheimer's disease : JAD · 2026

  28. 0.52

    Stage-dependent associations of glial fibrillary acidic protein and chitinase-3-like protein 1 with white matter network integrity in Alzheimer's disease

    Li OY, Turnbull A, Vankee-Lin F · Journal of Alzheimer's disease : JAD · 2026

  29. 0.52

    Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease

    Fu J, Lai X, Zhang C et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024

  30. 0.51

    Association of plasma glial fibrillary acidic protein and APOE-epsilon4 with Alzheimer's disease

    Zhu Y, Lan G, Li A et al. · Neurobiology of aging · 2026

  31. 0.51

    Semantic intrusion errors are associated with plasma Ptau-181 among persons with amnestic mild cognitive impairment who are amyloid positive

    Curiel Cid RE, Ortega A, Crocco EA et al. · Frontiers in neurology · 2023

05model · prediction14편

  1. 0.86

    APOE4 genotypes and the trajectory of biomarkers, neuroimaging, and cognitive measures in Alzheimer's Disease: A mixed-effects disease progression model

    Essenburg C, Ramanathan M · Journal of pharmacokinetics and pharmacodynamics · 2025

  2. 0.77

    A Multimodal Latent Severity Axis for Alzheimer's Disease: Probabilistic PCA, Bayesian Trajectories, and Stage-Aware Timing Effects

    Haji B, Tahami Monfared AA · Neurology and therapy · 2026

  3. 0.76

    Sensitivity comparison of longitudinal cognitive function indicators of Alzheimer's disease after mild cognitive impairment: a prospective cohort study

    Guo G, Song W, Wang A et al. · Scientific reports · 2026

  4. 0.72

    Dynamics of Cognitive Impairment in MCI Patients over a Three-Year Period: The Informative Role of Blood Biomarkers, Neuroimaging, and Genetic Factors

    Morozova I, Zorkina Y, Berdalin A et al. · Diagnostics (Basel, Switzerland) · 2024

  5. 0.67

    Predicting the timing of first sustained cognitive worsening in Alzheimer's disease using real-world clinical data and machine learning

    Venkatesh S, Zhang S, Zhu W et al. · medRxiv : the preprint server for health sciences · 2026

  6. 0.61

    Predictors of Improvement after Cognitive Training in Mild Cognitive Impairment: Insights from the Cognitive Training and Neuroplasticity in Mild Cognitive Impairment Trial

    Qian M, Motter J, Deehan E et al. · Alzheimer disease and associated disorders · 2024

  7. 0.61

    A PARTIALLY FUNCTIONAL LINEAR REGRESSION FRAMEWORK FOR INTEGRATING GENETIC, IMAGING, AND CLINICAL DATA

    Li T, Yu Y, Marron JS et al. · The annals of applied statistics · 2024

  8. 0.60

    Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum

    Soch J, Richter A, Kizilirmak JM et al. · Brain : a journal of neurology · 2024

  9. 0.60

    Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE varepsilon4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease

    Niu X, Wang Y, Zhang X et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024

  10. 0.54

    Applying a statistical model-based AI method to identify prognostic factors for long-term cognitive decline in Alzheimer's disease: Evidence from pooled placebo data of four phase III trials

    Hanazawa R, Sato H, Suzuki K et al. · International journal of medical informatics · 2026

  11. 0.54

    Association of ApoE epsilon4 allele, homocysteine, and inflammatory factors (hs-CRP, IL-6, TNF-alpha) with cognitive dysfunction in Alzheimer's disease patients and development and validation of a predictive model

    Wang L, Sun Q · Neurological research · 2026

  12. 0.52

    Kinematic correlates of early speech motor changes in cognitively intact APOE-epsilon4 carriers: a preliminary study using a color-word interference task

    Dadgostar M, Hanford LC, Green JR et al. · Frontiers in neurology · 2025

  13. 0.50

    Conversion to Mild Cognitive Impairment and Alzheimer's Disease Dementia Related to Apathy, APOE Genotype and Antidepressant Use

    Malik R, Martinez MR, So I et al. · Journal of geriatric psychiatry and neurology · 2025

  14. 0.50

    Towards the development of a management protocol for subjective cognitive decline: Insights from a cross-sectional and longitudinal analysis of multimodal data from a memory clinic

    Mazzeo S, Lassi M, Padiglioni S et al. · Journal of Alzheimer's disease : JAD · 2026

06mice · apoe48편

  1. 0.70

    The Effect of FTY720 on Sphingolipid Imbalance and Cognitive Decline in Aged EFAD Mice

    Luo Q, Crivelli SM, Zong S et al. · Journal of Alzheimer's disease reports · 2024

  2. 0.69

    Smelling the Risk: Early Olfactory Deficits, Brain Networks, and Blood Markers of Alzheimer's Disease Risk in Humanized APOE Mice

    Moon HS, Han ZY, Anderson RJ et al. · bioRxiv : the preprint server for biology · 2025

  3. 0.59

    Effects of obesogenic diet and 17beta-estradiol in female mice with APOE 3/3, 3/4, and 4/4 genotypes

    Christensen A, McGill CJ, Qian W et al. · Frontiers in aging neuroscience · 2024

  4. 0.57

    The novel estrogen receptor beta agonist EGX358 and APOE genotype influence memory, vasomotor, and anxiety outcomes in an Alzheimer's mouse model

    Schwabe MR, Fleischer AW, Kuehn RK et al. · Frontiers in aging neuroscience · 2024

  5. 0.57

    Memory deficits in hypertensive ApoE4 mice reversed by P2Y12 inhibition via different mechanisms in males and perimenopausal females

    Trigiani L, Chernavsky N, Kim R et al. · Research square · 2025

  6. 0.54

    APOE epsilon4 allele drives female-specific Alzheimer's disease progression via vascular dysfunction and tau spreading

    Huang S, Wu J, He L · Frontiers in neuroscience · 2025

  7. 0.53

    Sex differences in cognition, anxiety-phenotype and therapeutic effect of metformin in the aged apoE-TR mice

    Lin Y, Luo X, Wang F et al. · Biology of sex differences · 2025

  8. 0.53

    Dihydrocaffeic acid alleviates APOE4-associated astrocyte dysfunction and cognitive impairment via LRP1/p38 MAPK signaling

    Shang J, Wang Y, Wang W et al. · Journal of ethnopharmacology · 2026

07review · mechanisms4편

  1. 0.74

    Uncovering Diverse Mechanistic Spreading Pathways in Disease Progression of Alzheimer's Disease

    Yu Z, Shi Z, Dan T et al. · Journal of Alzheimer's disease reports · 2023

  2. 0.57

    Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging

    Supiyev A, Karlsson R, Wang Y et al. · Neurobiology of aging · 2023

  3. 0.55

    Pharmacogenetics of angiotensin modulators according to APOE-ϵ4 alleles and the ACE insertion/deletion polymorphism in Alzheimer's disease

    Oliveira FFd, Almeida SSd, Chen ES et al. · Acta neuropsychiatrica · 2023

  4. 0.53

    Genetic drivers of progression in Alzheimer's disease are distinct from disease risk

    Cohen CE, Fernandez S, Yaman U et al. · Alzheimer's research & therapy · 2026

08imaging abnormalities · treatment1편

  1. 0.53

    The influence of bapineuzumab and semagacestat on rapid progressors: A retrospective cohort study

    Harris K, Shyer M, Wang D et al. · The journal of prevention of Alzheimer's disease · 2026